Analysts Recommendations Paratek Pharmaceuticals, Inc. (NASDAQ:PRTK): Campbell Soup Company(NYSE:CPB)

0
2

Paratek Pharmaceuticals, Inc. (PRTK) will report its next earnings on Feb 25 AMC. The company reported the earnings of $-1/Share in the last quarter where the estimated EPS by analysts was $-1.05/share. The difference between the expected and actual EPS was $0.05/share, which represents an Earnings surprise of 4.8%.

Many analysts are providing their Estimated Earnings analysis for Paratek Pharmaceuticals, Inc. and for the current quarter 5 analysts have projected that the stock could give an Average Earnings estimate of $-0.81/share. These analysts have also projected a Low Estimate of $-1.23/share and a High Estimate of $0.11/share.

In case of Revenue Estimates, 4 analysts have provided their consensus Average Revenue Estimates for Paratek Pharmaceuticals, Inc. as 14.84 Million. According to these analysts, the Low Revenue Estimate for Paratek Pharmaceuticals, Inc. is 4.53 Million and the High Revenue Estimate is 43.02 Million. The company had Year Ago Sales of 17.02 Million.

These analysts also forecasted Growth Estimates for the Current Quarter for PRTK to be -45.1%. They are projecting Next Quarter growth of 13.64%. For the next 5 years, Paratek Pharmaceuticals, Inc. is expecting Growth of 28.71% per annum, whereas in the past 5 years the growth was -16.53% per annum.

Some buy side analysts are also providing their Analysis on Paratek Pharmaceuticals, Inc. , where 2 analysts have rated the stock as Strong buy, 0 analysts have given a Buy signal, 0 said it’s a HOLD, and 0 analysts rated the stock as Sell. (These Recommendations are for the Current Month Only reported by Yahoo Finance.)

The Relative Volume of the company is 0.42 and Average Volume (3 months) is 1.18 million. The company’s P/E (price to earnings) ratio is 0 and Forward P/E ratio of 0.

The company shows its Return on Assets (ROA) value of -45.1%. The Return on Equity (ROE) value stands at 0%. While it’s Return on Investment (ROI) value is -37.8%.

While looking at the Stock’s Performance, Paratek Pharmaceuticals, Inc. currently shows a Weekly Performance of 2.33%, where Monthly Performance is -3.03%, Quarterly performance is 17.33%, 6 Months performance is -9.74% and yearly performance percentage is -50.84%. Year to Date performance value (YTD perf) value is -12.66%. The Stock currently has a Weekly Volatility of 4.52% and Monthly Volatility of 5.34%.

Campbell Soup Company (CPB) will report its next earnings on Mar 04 BMO. The company reported the earnings of $0.78/Share in the last quarter where the estimated EPS by analysts was $0.71/share. The difference between the expected and actual EPS was $0.07/share, which represents an Earnings surprise of 9.9%.

Many analysts are providing their Estimated Earnings analysis for Campbell Soup Company and for the current quarter 16 analysts have projected that the stock could give an Average Earnings estimate of $0.66/share. These analysts have also projected a Low Estimate of $0.61/share and a High Estimate of $0.75/share.

In case of Revenue Estimates, 14 analysts have provided their consensus Average Revenue Estimates for Campbell Soup Company as 2.15 Billion. According to these analysts, the Low Revenue Estimate for Campbell Soup Company is 2.1 Billion and the High Revenue Estimate is 2.23 Billion. The company had Year Ago Sales of 2.71 Billion.

These analysts also forecasted Growth Estimates for the Current Quarter for CPB to be -15.6%. They are projecting Next Quarter growth of 1.79%. For the next 5 years, Campbell Soup Company is expecting Growth of 5.27% per annum, whereas in the past 5 years the growth was 10% per annum.

Some buy side analysts are also providing their Analysis on Campbell Soup Company, where 1 analysts have rated the stock as Strong buy, 0 analysts have given a Buy signal, 2 said it’s a HOLD, and 0 analysts rated the stock as Sell. (These Recommendations are for the Current Month Only reported by Yahoo Finance.)

The Relative Volume of the company is 1.18 and Average Volume (3 months) is 2 million. The company’s P/E (price to earnings) ratio is 31.24 and Forward P/E ratio of 18.05.

The company shows its Return on Assets (ROA) value of 0%. The Return on Equity (ROE) value stands at 0%. While it’s Return on Investment (ROI) value is 8.7%.

While looking at the Stock’s Performance, Campbell Soup Company currently shows a Weekly Performance of -1.27%, where Monthly Performance is -1.92%, Quarterly performance is -0.54%, 6 Months performance is 9.94% and yearly performance percentage is 46.27%. Year to Date performance value (YTD perf) value is -2.83%. The Stock currently has a Weekly Volatility of 1.46% and Monthly Volatility of 1.41%.

SHARE